Keith Riccardi - Concepedia

Author

Keith Riccardi

Pfizer (United States)

Also Known As

K Riccardi, K. A. Riccardi, K. Riccardi, K.A. Riccardi, Keith A. Riccardi, Keith Riccardi, Riccardi, Keith

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)

About

Keith Riccardi is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	532
2	Natural Sciences	6	6	448
3	Engineering	3	3	241
4	Health Sciences	1	1	11
5	Public Health	1	1	11

Keith Riccardi

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents Brett S. Robinson, Keith Riccardi, Yi-Fei Gong, Antimicrobial Agents and Chemotherapy	2000	195
Systematic Evaluation of Bioorthogonal Reactions in Live Cells with Clickable HaloTag Ligands: Implications for Intracellular Imaging Heather E. Murrey, Joshua C. Judkins, Christopher W. am Ende, Journal of the American Chemical Society EngineeringBioorthogonal ReactionsClickable HalotagImaging AgentMolecular Biology	2015	188
Plasma Protein Binding of Challenging Compounds Keith Riccardi, Shannon Cawley, Phillip D. Yates, Journal of Pharmaceutical Sciences Protein ChemistryProtein AssemblyBiochemistryProtein FoldingNatural Sciences	2015	110
A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling Rui Li, Hugh A. Barton, Phillip D. Yates, Journal of Pharmacokinetics and Pharmacodynamics Pharmacokinetic ModelingMedicinePhysiologyHuman Pharmacokinetic PredictionsMetabolism	2014	77
Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5) Kim Huard, Janice A. Brown, Jessica Jones, Scientific Reports Medicinal ChemistryBiochemistryCitrate TransportLiver PhysiologyNatural Sciences	2015	68
Inhibitors of HIV-1 attachment. Part 7: Indole-7-carboxamides as potent and orally bioavailable antiviral agents Kap-Sun Yeung, Zhilei Qiu, Quifen Xue, Bioorganic & Medicinal Chemistry Letters MedicineImmunologyAntiviral ResponseAntiviral Drug DevelopmentBioavailable Antiviral Agents	2012	51
Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes Keith Riccardi, Jian Lin, Zhenhong Li, Drug Metabolism and Disposition	2017	49
A Novel Unified Approach to Predict Human Hepatic Clearance for Both Enzyme- and Transporter-Medated Mechanisms Using Suspended Human Hepatocytes Keith Riccardi, David A. Tess, Jian Lin, Drug Metabolism and Disposition	2019	45
Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor P F Lin, Himadri Samanta, Clifford Bechtold, Antimicrobial Agents and Chemotherapy Human Immunodeficiency VirusFusion Inhibitor SiamycinMedicineHuman RetrovirusImmunology	1996	43
Comparison of Species and Cell-Type Differences in Fraction Unbound of Liver Tissues, Hepatocytes, and Cell Lines Keith Riccardi, Sangwoo Ryu, Jian Lin, Drug Metabolism and Disposition	2018	41

Page 1